학술논문
P-249 Aflibercept-based and bevacizumab-based second-line regimens in patients with RAS/BRAF wild type metastatic colorectal cancer: Propensity score weighted-analysis from a multicenter cohort
Document Type
Abstract
Author
Source
In Annals of Oncology June 2023 34 Supplement 1:S103-S104
Subject
Language
ISSN
0923-7534